Othman Laraki, Color CEO, on surviving three major pivots
In this episode, Christina Farr sits down with Othman Laraki, co-founder and CEO of Color. They discuss the "tortuous" yet rewarding journey of building a generational healthcare company.
In this episode, Christina Farr sits down with Othman Laraki, co-founder and CEO of Color. They discuss the "tortuous" yet rewarding journey of building a generational healthcare company.
In this episode of Lifers, Christina Farr examines the intricate intersection of clinical oversight and product strategy with Dr. Ari Hoffman, who oversees both domains at Collective Health. They discuss the only “because healthcare" realities that define the sector.
In this episode of Lifers, Christina Farr speaks with Dr. Zeke Emanuel about his new book, Eat Your Ice Cream, which offers a sustainable alternative to the aggressive trend of health optimization.
In this episode of Lifers, Christina Farr sits down with Dr. Bob Wachter, Chair of the Department of Medicine at
This week on Lifers, Niyum Gandhi, CFO of Mass General Brigham, and Mike Desjadon, CEO of Anomaly, discuss the financial pressures facing health systems today.
Dr. Kameron Matthews (Chief Health Officer, Impact Care) and Shelli Pavone (President & Co-Founder, Inlightened) join Chrissy Farr to tackle healthcare's biggest challenges: the Medicaid crisis, state licensing chaos, the death of primary care, and why Silicon Valley keeps getting it wrong.
This week on Lifers, Christina Farr sat down with Sachin Jain, CEO of SCAN Health Plan. Sachin makes a compelling case for "radical common sense" in healthcare—the idea that we've normalized dysfunction for so long that simple, patient-centered solutions now feel revolutionary.
This week on Lifers, Christina Farr sat down with Mike Desjadon, CEO of Anomaly and Warris Bokhari CEO of Claimable. They discuss automating patient appeals, the challenges of the current payment model, and their approach to working directly with patients.
In this episode of Lifers, Christina Farr engages in an insightful conversation with V, CEO of Sword Health.
Chrissy Farr sits down with Michelle Carnahan, who spent 26 years at Eli Lilly witnessing the development of breakthrough GLP-
In this episode of the Second Opinion, Christina Farr interviews Dickon Waterfield, president of Lantern to discuss the intricacies of U.S. healthcare costs, particularly the disparity between Medicare and commercial prices.
In this episode of Second Opinion, Christina Farr and Lifeforce CEO Dugal Bain-Kim dive into the billion-dollar longevity economy, examining why health optimization became a status symbol and how personal data drives better health decisions than population-level advice.